Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro (tirzepatide) is not directly licensed to alter menstrual cycles, yet changes to periods are among the most commonly reported experiences by women starting treatment. Some notice heavier or more frequent periods; others find their cycle becomes irregular or temporarily stops. These effects are real, and they matter — you deserve a clear explanation of why they happen and what to watch for. Mounjaro is a prescription-only medicine that requires clinical assessment before it can be prescribed, and a prescriber is best placed to discuss anything unexpected happening with your cycle.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
This is the situation a surprising number of women find themselves in, and the first thing to say is: you are not imagining it, and you are not alone. The confusion is understandable because Mounjaro's licence says nothing about menstruation. It is approved for weight management and type 2 diabetes. So why is your cycle suddenly different?
The short answer is that weight loss itself is a powerful hormonal event. Fat tissue produces and stores oestrogen, and as adipose mass falls (sometimes quickly in the early weeks of tirzepatide treatment) oestrogen levels fluctuate. The hypothalamic-pituitary-ovarian axis, which times ovulation and menstruation, is sensitive to these shifts. A rapid change in body weight can be enough to push a cycle off-schedule, make a period heavier than usual, or temporarily suppress it altogether. None of this is unique to Mounjaro; it is a documented consequence of significant weight loss by any means. What makes tirzepatide notable is simply how effective it is, meaning these hormonal ripples can arrive faster and more noticeably than they might after a slow dietary change.
The NHS patient information page for tirzepatide does not list menstrual irregularity as a formally recognised side effect of the drug itself, which is worth knowing — it helps distinguish a medicine-direct effect from a weight-change-driven one. For a fuller picture of the effects Mounjaro can have on your period, including why cycles respond the way they do during treatment, this page breaks down the mechanisms in plain language. For a fuller picture of the treatment and how it works, the tirzepatide overview on this site covers the dual GIP and GLP-1 mechanism in plain language.
For women with polycystic ovary syndrome, the picture can be the reverse of what you might expect. PCOS is closely linked to insulin resistance and elevated androgen levels, both of which interfere with regular ovulation. As tirzepatide improves insulin sensitivity and weight falls, some women with PCOS find that cycles which were previously absent or wildly irregular begin to regularise.
This can feel like good news, and in many ways it is. But it comes with an important corollary: if your periods return after a long absence, so does the possibility of ovulation, and with it the possibility of pregnancy. A question our prescribers hear fairly often is whether this means someone who previously thought they were unlikely to conceive needs to reconsider contraception. The honest answer is yes, it is worth discussing with your GP.
Fertility changes during weight loss treatment are not something to handle on the basis of what felt true before starting. This sits squarely in the territory of a conversation with a clinician rather than something to manage by guesswork. You can find more about the broader range of effects Mounjaro can have beyond weight loss, which provides useful context for discussions like this one.
One effect that is grounded in the medicine's known pharmacology, not just the consequence of weight change, concerns oral contraceptives. Mounjaro slows gastric emptying, the rate at which your stomach pushes food and liquids into the intestine. This slowing can reduce how reliably an oral contraceptive pill is absorbed, particularly early in treatment when gastric-emptying effects are most pronounced.
NHS guidance is clear on this: women taking the oral contraceptive pill should use an additional non-oral method of contraception (condoms are the practical choice) during the first four weeks of Mounjaro treatment and for four weeks after each dose increase. The NHS England guidance on weight-management injections sets this out explicitly. There is no equivalent published evidence for semaglutide reducing pill absorption to the same degree, so this is a tirzepatide-specific note.
If you switched from a different treatment and moved straight to a higher Mounjaro dose, the four-week window still applies from that increase. If your period has already changed and you are unsure whether your pill was reliably absorbed in the early weeks, speaking to a GP quickly is the right step. It is also worth reading about the question of missing a period on Mounjaro specifically, which goes into this scenario in more detail.
Most menstrual changes in the first weeks of Mounjaro settle as the body adjusts to both the medicine and to losing weight. That said, some changes warrant prompt medical input rather than a wait-and-see approach.
A missed period always deserves attention if pregnancy is in any way possible, given the contraceptive-absorption point above. Mounjaro is not recommended during pregnancy, and the MHRA advises using effective contraception throughout treatment and for a wash-out period before trying to conceive. Unusually heavy bleeding, cycles shorter than 21 days or longer than 35, or pain that is markedly different from your normal experience are all worth discussing with a GP rather than attributing to Mounjaro without ruling other causes out.
If you are considering starting treatment and want to understand whether Mounjaro can affect periods before you begin, that page gives a pre-treatment framing. Likewise, if you want to look at cost and see whether private treatment makes sense for your situation, the Mounjaro cost guide explains what private pricing includes and why the prescription and clinical review are part of what you are paying for, not extras bolted on later. If you would like a prescriber to look at your full picture, including anything going on with your cycle, a free consultation with our clinical team is the starting point.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.